» login


Please sign in

Non-invasive assessment of cardiovascular risk and risk of diabetes

Clinically validated, convenient and easy to use

News: As of January 1st, 2014 DiagnOptics Technologies B.V. moved to another location.

Our new premises will allow for the ongoing growth of our organization and activities. We are confident that our enhanced new facilities and office location will enable us to better serve you as our customers.

Telephone, fax and email adresses will remain unchanged.


Diabetes screening Diab Spot picture

Diab-spot is a non-invasive test to identify people at risk for diabetes or pre-diabetes without overnight fasting, a blood draw, or waiting for a lab result.

  • More accurate than FPG or HbA1c
  • Easy to use
  • Fast (within 1 minute)
  • Cost-effective

AGE Reader

Cardiovascular risk assesment Age Reader picture

The AGE Reader provides an immediate cardiovascular risk prediction in major chronic diseases such as diabetes, renal failure and cardiovascular disease.

  • Clinically validated
  • Non-invasive point-of-care test
  • Safe and convenient
  • Cost-effective
Latest news

Breakthrough publication: AGE Reader in atherosclerosis

Groningen, the Netherlands - March 11, 2014. A recently published clinical paper by de Vos et al. (2014) demonstrates that the AGE Reader measurement is a str......

» read more

The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or DiagnOptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.

About the company

Find information about DiagnOptics.

Information for patients

Find information about DiagnOptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.